To investigate the contribution of p21 to tumor formation and progression in breast cancer, we used a bone-metastatic cell line SCP2, a sub-progeny of the human triple negative breast cancer MDA-MB231 (hereafter referred to as MDA) cells [35]. This evidence concerns the gene CDKN1A and breast cancer.